Abbott announced contract to supply millions of IgG lab-based antibody tests to UK government
On May 21, 2020, Abbott announced a government contract to supply millions of its laboratory-based IgG antibody tests…
-
-
Abbott released interim clinical study data on ID NOW COVID-19 rapid test showing strong agreement to lab-based molecular PCR tests
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
-
AstraZeneca advanced response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
-
bioMerieux serology tests for SARS-CoV-2 on VIDAS received CE marking
On May 21, 2020, bioMerieux announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to detect antibodies in people…
-
University of British Columbia researchers developed biodegradable medical mask for COVID-19
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
-
ADMA Biologics commenced collection of COVID-19 plasma from recovered patients
On May 21, 2020, ADMA Biologics announced it had commenced the collection of convalescent plasma through its wholly-owned…
-
Mammoth Biosciences collaborated with GSK to develop COVID-19 test using CRISPR-based platform
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
-
Vaxart announced selection of its oral COVID-19 vaccine lead candidate
On May 20, 2020, Vaxart announced it has entered into an agreement with Vaxart for the manufacture of…
-
ViralClear closed $10.8 million equity financing for development of COVID-19 broad-spectrum oral anti-viral candidate merimepodib
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
-
Rapid Micro Biosystems raised $120 million to accelerate global expansion of contaminant testing platform for pharmaceutical and vaccine manufacturing
On May 20, 2020, Rapid Micro Biosystems announced a $120 million financing round, led by equity investment from…
-
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
-
Bharat Biotech and Thomas Jefferson University announced a promising vaccine candidate against COVID-19
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
-
ARENSIA Begins Clinical Trial Program to Test Diffusion’s Lead Drug for the Treatment of Hospitalized COVID-19 Patients
On May 20, 2020, ARENSIA announced an agreement with Diffusion Pharmaceuticals to begin a clinical trial program to test…
-
Atossa Therapeutics announced in vitro testing results of COVID-19 drug inhibits SARS-CoV-2 infectivity
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossa’s proprietary COVID-19 drug…
-
Phlow Corp was awarded $354 million BARDA contract to manufacture essential medicines in shortage
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
-
CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
-
Llama antibody engineered to block Coronavirus
On May 19, 2020, the National Institutes of Health (NIH) reported that researchers from the University of Texas,…
-
USC antibody study showed coronavirus infection more widespread in LA County than previously thought
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
-
Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
-
Oragenics and Aragen Bioscience enter agreement to accelerate development of TerraCoV2, a SARS-CoV-2 (COVID 19) vaccine candidate
On May 19, 2020, Oragenics announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an…
-
Bio-Techne and Kantaro Biosciences announced partnership to develop and scale production of COVID-19 serology test
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
-
Roche highly accurate antibody test for COVID-19 went live at more than 20 initial lab sites in the US
On May 19, 2020, Roche announced its Elecsys Anti-SARS-CoV-2 antibody test is live at more than 20 commercial…
-
New study from pandemic epicenter described severe COVID-19 response in children
On May 19, 2020, the Albert Einstein College of Medicine reported that while most children infected with the…
-
Global study tested malaria drug to protect health workers from COVID-19
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
-
NantKwest announced FDA authorization of IND application for mesenchymal stem cell product for treatment of severe COVID-19 patients
On May 18, 2020, NantKwest, now part of ImmunityBio, announced it had received authorization from the U.S. Food…
-
Quidel’s Lyra Direct SARS-CoV-2 assay received Emergency Use Authorization and CE Mark for molecular detection of COVID-19
On May 18, 2020, Quidel announced it had received Emergency Use Authorization (EUA) for the Lyra Direct SARS-CoV-2…
-
FDA cleared IND application to enable phase II trial of ViralClear’s merimepodib to treat adult patients with advanced COVID-19 to proceed
On May 18, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the U.S. Food and Drug Administration…
-
Thermo Fisher Scientific support of COVID-19 response expanded with US Government contract for products used in sample collection
On May 18, 2020, Thermo Fisher Scientific announced it had received a contract from the U.S. government to…
-
Todos Medical announced first commercial sale of COVID-19 antibody tests
On May 18, 2020, Todos Medical announced its first commercial sale of COVID-19 tests. The sale was made…
-
Biotechnology | COVID-19 | Infectious Disease | NIH | USDA | Vaccine
Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia
On May 16, 2020, a single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six…
